interleukin-1beta (163-171) has been researched along with naloxone in 1 studies
| Studies (interleukin-1beta (163-171)) | Trials (interleukin-1beta (163-171)) | Recent Studies (post-2010) (interleukin-1beta (163-171)) | Studies (naloxone) | Trials (naloxone) | Recent Studies (post-2010) (naloxone) |
|---|---|---|---|---|---|
| 192 | 3 | 74 | 20,134 | 1,257 | 3,321 |
| Protein | Taxonomy | interleukin-1beta (163-171) (IC50) | naloxone (IC50) |
|---|---|---|---|
| Cytochrome P450 2D6 | Homo sapiens (human) | 2 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.043 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0219 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0019 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0019 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.0397 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.1896 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.05 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.0795 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.0154 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0089 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.0055 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YY; Huang, CJ; Kao, MC; Lin, HY | 1 |
1 other study(ies) available for interleukin-1beta (163-171) and naloxone
| Article | Year |
|---|---|
Naloxone inhibits nod-like receptor protein 3 inflammasome.
Topics: Adenosine Triphosphate; Anti-Inflammatory Agents; Biomarkers; Cell Line; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Humans; Inflammasomes; Interleukin-1beta; Lipopolysaccharides; Naloxone; NLR Family, Pyrin Domain-Containing 3 Protein; Peptide Fragments; Random Allocation; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation | 2017 |